HIV Treatment: New Antibody Study

We are investigating whether adding a new antibody to current HIV medications helps reduce the viral reservoir in adults living with HIV. This study aims to improve treatment outcomes for those affected.

>2 yearsSafety phase (I)Infectious DiseasesInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Universitair Ziekenhuis Gent
Department of Internal Medicine
Ledeberg, Belgium
CHU Saint Pierre
Department of Internal Medicine
Saint-Gilles, Belgium
Region Midtjylland
Department of Infectious Diseases
Århus, Denmark

Sponsor: Viiv Healthcare UK Limited
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.